184 related articles for article (PubMed ID: 12161380)
1. Typical chronic myelogenous leukemia with e19a2 BCR/ABL transcript. Report of two cases.
Martínez-López J; Ayala R; Albizua Q
Haematologica; 2002 Aug; 87(8):ELT35. PubMed ID: 12161380
[No Abstract] [Full Text] [Related]
2. Clonal evolution with double Ph followed by tetraploidy in imatinib-treated chronic myeloid leukemia with e19a2 transcript in transformation.
Oshikawa G; Kurosu T; Arai A; Murakami N; Miura O
Cancer Genet Cytogenet; 2010 May; 199(1):56-61. PubMed ID: 20417871
[TBL] [Abstract][Full Text] [Related]
3. Detection of the Philadelphia chromosome in paraffin-embedded tissue by fluorescence in situ hybridization.
Brynes RK; McCourty A; Ho JP; Traweek ST; Snyder DS; Slovak ML
Mod Pathol; 1994 Jun; 7(5):565-9. PubMed ID: 7937723
[TBL] [Abstract][Full Text] [Related]
4. A multiplex PCR for improved detection of typical and atypical BCR-ABL fusion transcripts.
Burmeister T; Reinhardt R
Leuk Res; 2008 Apr; 32(4):579-85. PubMed ID: 17928051
[TBL] [Abstract][Full Text] [Related]
5. Alu and translisin recognition site sequences flanking translocation sites in a novel type of chimeric bcr-abl transcript suggest a possible general mechanism for bcr-abl breakpoints.
Martinelli G; Terragna C; Amabile M; Montefusco V; Testoni N; Ottaviani E; de Vivo A; Mianulli A; Saglio G; Tura S
Haematologica; 2000 Jan; 85(1):40-6. PubMed ID: 10629590
[TBL] [Abstract][Full Text] [Related]
6. Complete cytogenetic and molecular response after imatinib treatment for chronic myeloid leukemia in a patient with atypical karyotype and BCR-ABL b2a3 transcript.
Pienkowska-Grela B; Woroniecka R; Solarska I; Kos K; Pastwińska A; Konopka L; Majewski M
Cancer Genet Cytogenet; 2007 Apr; 174(2):111-5. PubMed ID: 17452251
[TBL] [Abstract][Full Text] [Related]
7. [Bcr-abl translocation: diagnostic methods and clinical value].
Pignon JM
Ann Biol Clin (Paris); 1998; 56(1):57-63. PubMed ID: 9754223
[TBL] [Abstract][Full Text] [Related]
8. Chronic myelogenous leukemia with e13a3 (b2a3) type of BCR-ABL transcript having a DNA breakpoint between ABL exons a2 and a3.
Liu LG; Tanaka H; Ito K; Kyo T; Ito T; Kimura A
Am J Hematol; 2003 Dec; 74(4):268-72. PubMed ID: 14635208
[TBL] [Abstract][Full Text] [Related]
9. Chronic myelogenous leukemia with the e6a2 BCR-ABL and lacking imatinib response: presentation of two cases.
Vefring HK; Gruber FX; Wee L; Hovland R; Hjorth-Hansen H; Gedde Dahl T; Meyer P
Acta Haematol; 2009; 122(1):11-6. PubMed ID: 19641300
[TBL] [Abstract][Full Text] [Related]
10. Generation of the BCR/ABL fusion gene in a Philadelphia chromosome-negative chronic myeloid leukaemia: insertion of 5.6 Mb of 9q34 into the BCR region of chromosome 22.
Valle L; Fernández V; Pérez-Pons C; Sánchez FG; Benítez J; Urioste M
Hematol Oncol; 2006 Jun; 24(2):86-8. PubMed ID: 16598834
[TBL] [Abstract][Full Text] [Related]
11. e19a2-positive chronic myeloid leukaemia with BCR exon e16-deleted transcripts.
Wang L; Seale J; Woodcock BE; Clark RE
Leukemia; 2002 Aug; 16(8):1562-3. PubMed ID: 12145699
[No Abstract] [Full Text] [Related]
12. Unique secondary chromosomal abnormalities are frequently found in the chronic phase of chronic myeloid leukemia in southern Vietnam.
Phan TX; Hoang AV; Huynh VM; Nguyen KT; Nguyen TB; Huynh N; Pham QT; Tran VB; Tran VB; Tokunaga K; Sato Y
Cancer Genet Cytogenet; 2006 Jul; 168(1):59-68. PubMed ID: 16772122
[TBL] [Abstract][Full Text] [Related]
13. Differential display analysis of mRNAs in chronic myelogenous leukaemia.
el-Awady MK; Abdalla NM; Salem AM; Samir S; Nour AM
East Mediterr Health J; 2001; 7(4-5):707-15. PubMed ID: 15332769
[TBL] [Abstract][Full Text] [Related]
14. ABL-BCR mRNAs transcribed from chromosome 9q+ in Philadelphia-chromosome-positive chronic myeloid leukaemia.
MacKenzie E; Stewart E; Birnie GD
Leukemia; 1993 May; 7(5):702-6. PubMed ID: 8483322
[TBL] [Abstract][Full Text] [Related]
15. Chronic myeloid leukemia with a rare variant BCR-ABL translocation: t(9;22;21)(q34;q11.2;q11.2).
Takeuchi M; Katayama Y; Okamura A; Yamamoto K; Shimoyama M; Matsui T
Cancer Genet Cytogenet; 2007 Nov; 179(1):85-7. PubMed ID: 17981222
[No Abstract] [Full Text] [Related]
16. A case of chronic myelogenous leukemia with e8a2 fusion transcript.
Park IJ; Lim YA; Lee WG; Park JS; Kim HC; Lee HJ; Cho SR
Cancer Genet Cytogenet; 2008 Sep; 185(2):106-8. PubMed ID: 18722880
[TBL] [Abstract][Full Text] [Related]
17. Novel types of bcr-abl transcript with breakpoints in BCR exon 8 found in Philadelphia positive patients with typical chronic myeloid leukemia retain the sequence encoding for the DBL- and CDC24 homology domains but not the pleckstrin homology one.
Martinelli G; Amabile M; Giannini B; Terragna C; Ottaviani E; Soverini S; Saglio G; Rosti G; Baccarani M
Haematologica; 2002 Jul; 87(7):688-94; discussion 694. PubMed ID: 12091118
[TBL] [Abstract][Full Text] [Related]
18. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
[TBL] [Abstract][Full Text] [Related]
19. [Two Ph chromosome positive chronic myelogenous leukemia patients with rare bcr/abl fusion gene].
Qin YZ; Liu YR; Li JL; Wang H; Chang Y; Fu JY; Ruan GR; Shi HL; Qiu JY; Lu DP; Chen SS
Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):409-12. PubMed ID: 15355693
[TBL] [Abstract][Full Text] [Related]
20. First and second line imatinib treatment in chronic myelogenous leukemia patients expressing rare e1a2 or e19a2 BCR-ABL transcripts.
Andrikovics H; Nahajevszky S; Szilvási A; Bors A; Adám E; Kozma A; Kajtár B; Barta A; Poros A; Tordai A
Hematol Oncol; 2007 Sep; 25(3):143-7. PubMed ID: 17530620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
